These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis. Rösener M; Hahn H; Kranz M; Heeney J; Rethwilm A J Med Virol; 1996 Mar; 48(3):222-6. PubMed ID: 8801281 [TBL] [Abstract][Full Text] [Related]
11. Cerebral magnetic resonance imaging pathology and cerebro-spinal fluid protein in sporadic amyotrophic lateral sclerosis (sALS). Westarp ME; Schreiber H; Westarp MP; Westphal KP; Mauch E; Kornhuber HH Clin Neuropathol; 1995; 14(4):228-32. PubMed ID: 8521627 [TBL] [Abstract][Full Text] [Related]
12. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis. Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013 [TBL] [Abstract][Full Text] [Related]
13. [Amyotrophic lateral sclerosis and anti-CV2 antibodies. Paraneoplastic association?]. García Martín G; Perez Errazquin F; Chamorro Muñoz M; Romero Acebal M Neurologia; 2007; 22(6):406-9. PubMed ID: 17610172 [TBL] [Abstract][Full Text] [Related]
14. A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis. Ragheb S; Lisak R; Lewis R; Van Stavern G; Gonzales F; Simon K Arch Neurol; 2008 Oct; 65(10):1358-62. PubMed ID: 18852352 [TBL] [Abstract][Full Text] [Related]
15. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). Zhang R; Gascon R; Miller RG; Gelinas DF; Mass J; Hadlock K; Jin X; Reis J; Narvaez A; McGrath MS J Neuroimmunol; 2005 Feb; 159(1-2):215-24. PubMed ID: 15652422 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. Gurney ME; Belton AC; Cashman N; Antel JP N Engl J Med; 1984 Oct; 311(15):933-9. PubMed ID: 6472419 [TBL] [Abstract][Full Text] [Related]
17. A molecular genetic approach to amyotrophic lateral sclerosis. Siddique T; Hu P; Hentati A; Deng G; Hung WY; McInnis MG; Warren AC; Rimmler J; Antonarakis S; Pericak-Vance MA Int J Neurol; 1991-1992; 25-26():60-9. PubMed ID: 11980064 [TBL] [Abstract][Full Text] [Related]
18. [Clinico-immunological research on patients with different forms of amyotrophic lateral sclerosis]. Lobzin VS; Zvegintsova TN; Orlov AB Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(3):42-4. PubMed ID: 1646537 [TBL] [Abstract][Full Text] [Related]
19. Cellular immunity in Guamanians with amyotrophic lateral sclerosis and Parkinsonism-dementia. Hoffman PM; Robbins DS; Nolte MT; Gibbs CJ; Gajdusek DC N Engl J Med; 1978 Sep; 299(13):680-5. PubMed ID: 308183 [TBL] [Abstract][Full Text] [Related]